Fortis Healthcare Ltd Peer Comparison - Competitive Analysis

Fortis Healthcare unit inks 15-year pact with RR Lifesciences

 Copy Link

Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.

Fortis Healthcare’s Q1 Profit Rises 10% to ₹152 Crore

 Copy Link

Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.

Fortis Healthcare’s Subsidiary IHL Faces ₹76.19 Crore Tax Demand

 Copy Link

The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.

Top Stocks for Today - 4th April 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.

Fortis Healthcare Q3 Profit Soars 89.5% YoY, Revenue Up 14.8%

 Copy Link

EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.

Fortis Healthcare Boosts Stake in Agilus Diagnostics with ₹429 Crore IFC Deal

 Copy Link

The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.

Fortis Healthcare Reports 1.6% Profit Growth, 12.3% Revenue Increase in Q2

 Copy Link

Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.

Fortis Buys Out PE Investors in Diagnostics Arm

 Copy Link

Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.